B7-H3 downregulation results in markedly decreased tumor growth in mouse models with loss of TSC2 and mTORC1 hyperactivation (Fig. 5a–c and Supplementary Fig. 3g, h, 4a–f). The gene discussed is CD276; the disease is neoplasm.